221 related articles for article (PubMed ID: 20683902)
21. Cytokines secreted by bone-metastatic breast cancer cells alter the expression pattern of f-actin and reduce focal adhesion plaques in osteoblasts through PI3K.
Mercer RR; Mastro AM
Exp Cell Res; 2005 Nov; 310(2):270-81. PubMed ID: 16154565
[TBL] [Abstract][Full Text] [Related]
22. Extracellular Vesicles From Osteotropic Breast Cancer Cells Affect Bone Resident Cells.
Loftus A; Cappariello A; George C; Ucci A; Shefferd K; Green A; Paone R; Ponzetti M; Delle Monache S; Muraca M; Teti A; Rucci N
J Bone Miner Res; 2020 Feb; 35(2):396-412. PubMed ID: 31610048
[TBL] [Abstract][Full Text] [Related]
23. Secretory products of breast cancer cells specifically affect human osteoblastic cells: partial characterization of active factors.
Siwek B; Lacroix M; De Pollak C; Marie P; Body JJ
J Bone Miner Res; 1997 Apr; 12(4):552-60. PubMed ID: 9101366
[TBL] [Abstract][Full Text] [Related]
24. Bone morphogenetic proteins secreted by breast cancer cells upregulate bone sialoprotein expression in preosteoblast cells.
Bunyaratavej P; Hullinger TG; Somerman MJ
Exp Cell Res; 2000 Nov; 260(2):324-33. PubMed ID: 11035927
[TBL] [Abstract][Full Text] [Related]
25. Osteoblast-secreted WISP-1 promotes adherence of prostate cancer cells to bone via the VCAM-1/integrin α4β1 system.
Chang AC; Chen PC; Lin YF; Su CM; Liu JF; Lin TH; Chuang SM; Tang CH
Cancer Lett; 2018 Jul; 426():47-56. PubMed ID: 29627497
[TBL] [Abstract][Full Text] [Related]
26. Microarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis.
Morrison C; Mancini S; Cipollone J; Kappelhoff R; Roskelley C; Overall C
J Biol Chem; 2011 Sep; 286(39):34271-85. PubMed ID: 21784845
[TBL] [Abstract][Full Text] [Related]
27. Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase.
Fong JE; Le Nihouannen D; Komarova SV
J Biol Chem; 2010 Oct; 285(41):31427-34. PubMed ID: 20679341
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells.
Chiovaro F; Martina E; Bottos A; Scherberich A; Hynes NE; Chiquet-Ehrismann R
Int J Cancer; 2015 Oct; 137(8):1842-54. PubMed ID: 25868708
[TBL] [Abstract][Full Text] [Related]
29. Location matters: osteoblast and osteoclast distribution is modified by the presence and proximity to breast cancer cells in vivo.
Brown HK; Ottewell PD; Evans CA; Holen I
Clin Exp Metastasis; 2012 Dec; 29(8):927-38. PubMed ID: 22562502
[TBL] [Abstract][Full Text] [Related]
30. Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions.
Shin HS; Sun HJ; Whang YM; Park YJ; Park DJ; Cho SW
Thyroid; 2021 May; 31(5):760-771. PubMed ID: 32791889
[No Abstract] [Full Text] [Related]
31. Paracrine effect of inflammatory cytokine-activated bone marrow mesenchymal stem cells and its role in osteoblast function.
Li C; Li G; Liu M; Zhou T; Zhou H
J Biosci Bioeng; 2016 Feb; 121(2):213-9. PubMed ID: 26315505
[TBL] [Abstract][Full Text] [Related]
32. Human-derived osteoblast-like cells and pericyte-like cells induce distinct metastatic phenotypes in primary breast cancer cells.
Mayo V; Bowles AC; Wubker LE; Ortiz I; Cordoves AM; Cote RJ; Correa D; Agarwal A
Exp Biol Med (Maywood); 2021 Apr; 246(8):971-985. PubMed ID: 33210551
[TBL] [Abstract][Full Text] [Related]
33. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
[TBL] [Abstract][Full Text] [Related]
34. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.
Pivetta E; Scapolan M; Pecolo M; Wassermann B; Abu-Rumeileh I; Balestreri L; Borsatti E; Tripodo C; Colombatti A; Spessotto P
Breast Cancer Res; 2011 Oct; 13(5):R105. PubMed ID: 22032644
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer cells induce osteoblast apoptosis: a possible contributor to bone degradation.
Mastro AM; Gay CV; Welch DR; Donahue HJ; Jewell J; Mercer R; DiGirolamo D; Chislock EM; Guttridge K
J Cell Biochem; 2004 Feb; 91(2):265-76. PubMed ID: 14743387
[TBL] [Abstract][Full Text] [Related]
36. Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone.
Tamura D; Hiraga T; Myoui A; Yoshikawa H; Yoneda T
Int J Oncol; 2008 Jul; 33(1):17-24. PubMed ID: 18575746
[TBL] [Abstract][Full Text] [Related]
37. Cytokines in osteoblast-conditioned medium promote the migration of breast cancer cells.
Chen X; Lu J; Ji Y; Hong A; Xie Q
Tumour Biol; 2014 Jan; 35(1):791-8. PubMed ID: 24026883
[TBL] [Abstract][Full Text] [Related]
38. Protease-activated receptor-2 dependent and independent responses of bone cells to prostate cancer cell secretory products.
Pagel CN; Kularathna PK; Sanaei R; Young ND; Hooper JD; Mackie EJ
Prostate; 2022 May; 82(6):723-739. PubMed ID: 35167724
[TBL] [Abstract][Full Text] [Related]
39. Myokines (muscle-derived cytokines and chemokines) including ciliary neurotrophic factor (CNTF) inhibit osteoblast differentiation.
Johnson RW; White JD; Walker EC; Martin TJ; Sims NA
Bone; 2014 Jul; 64():47-56. PubMed ID: 24721701
[TBL] [Abstract][Full Text] [Related]
40. CXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary Osteoblasts.
Pathak JL; Bakker AD; Verschueren P; Lems WF; Luyten FP; Klein-Nulend J; Bravenboer N
PLoS One; 2015; 10(6):e0131041. PubMed ID: 26103626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
